dr rahul anand yadav md dm neonatology hod kkcth
play

DR.RAHUL ANAND YADAV MD DM(NEONATOLOGY) HOD KKCTH When to us use? - PowerPoint PPT Presentation

DR.RAHUL ANAND YADAV MD DM(NEONATOLOGY) HOD KKCTH When to us use? Whic ich type of se seiz izur ures? es? How much(d (dose ose of d drug) g) to us use? Ho How lo long g to us use? MANDAN MISHRA SANKARACHA CHARY


  1. DR.RAHUL ANAND YADAV MD DM(NEONATOLOGY) HOD KKCTH

  2.  When to us use?  Whic ich type of se seiz izur ures? es?  How much(d (dose ose of d drug) g) to us use?  Ho How lo long g to us use?

  3. MANDAN MISHRA SANKARACHA CHARY RYA

  4. 1)Eye witness 2)Logic 3)Guidelines by authority in subject

  5.  Normal Neonatal Brain  Neonatal convulsions  Drug Action  Conclusions

  6.  Disturbed balance between excitatory and inhibitory neurotransmitters  Excitatory:Glutamat e Gaba  Inhibitory:Gaba Glutamate tamate

  7.  Subtle seizures  Multi focal clonic  Generalized tonic  Myoclonic

  8.  Signal al to noise ratio  SV2A 2A agonist ist • Synaptotagmin is a calcium • Depends upon levels of sensor for exocytosis in pre cytosolic calcium levels. synaptic vesicle leading to excitatory NT release into • When cytosolic calcium levels synaptic junction. are high, signal to noise ratio is altered resulting in • SV2A regulates the activity of seizures. synaptotagmin leading to inhibition of calcium mediated • Levetiracetam inhibits the exocytosis. release and influx of calcium into cytosol thereby reducing • Levetiracetam acts as an the signal to noise ratio agonist of synaptic vesicle protein 2A

  9.  Can be used in neonates  Do not use in subtle and generalized tonic seizures  “Use in Myocloni onic seizur ures, es, especi cial ally ly stimulus ulus sen ensi siti tive ve thalamocort mocortical ical myoclonus onus ”

  10. “DOES NOT EXIST”

  11.  When to use?  Which type of seizure to use?  How much to use?  How long to use?

  12. Status NOT EPILEPSY LEVETIRACET DIAZEPAM 4 hours Epilepticu AM RISK REDUCED s

  13. LEVETIRACETAM PHENOBARBITONE  Respiratory depressant  Respiratory depressant action present action absent  Myocardial depressant  Myocardial depressant action present action absent  Metabolic  Metabolic demand:? demand:Decreased  Multifocal clonic  Multifocal clonic seizure:useful seizure:use unknown  Myocl clonic onic: less useful  Myocloni clonic: c:more more useful ul  Drug interact ractions ions  Drug g interac acti tions ons present ent ab absent ent

  14.  Liver dysfunction  Liver dysfunction absent present  In instances where  In instances where there is increased there is increased levels of ammonia,it is levels of ammonia,it is safe unsafe  Pharmacoresistance  Pharmacoresistance not seen(MDR protein) seen LEV EVETIR ETIRAC ACETA ETAM VALPR LPROAT OATE

  15.  Loading dose :40mg/kg(some units start with 20mg/kg)  1cc=100mg…  “Accidental overdose reported but non fatal!”  Maintainance dose < 7 days-10mg/kg q8h > 7 days-20mg/kg q12h  Can use higher doses in exceptional circumstances

  16.  Dentate gyrus is a part of Hippocampus  Involved in episodic memory formation and exploration of new environment  LEV ,on prolonged use has potential side effects due to effect on dentate gyrus  Manifestations include Hyperactivity,psychosis ,tremors

  17.  Routinely don’t use  Can be used in stimulus sensitive myoclonic convulsions  Higher doses tolerated better  Stop as soon as primary etiology is better

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend